Difass International

Difass International is specialised in the design, development and promotion of Nutraceuticals, Cosmetics, Medical Devices and Food for Special Medical Purposes.


difass en en 007

The Company

On a daily basis, Difass International promptly provides useful and high quality health products to Doctors and builds partnerships with important national and international pharmaceutical companies.


difass en en 007

News and PR

Products difass en en 009

Difass: the new challenge of International E–Commerce

Fairs and conventions difass en en 010

ECM Distance Learning Course PRINCIPLES OF DIETETICS AND CLINICAL NUTRITION

Products difass en en 011

Difass International always by the side of its Partners: REMOTE SALES–FORCE TRAINING

Publications difass en en 012

DIFASS – INTELLECTUAL PROPERTY

Products difass en en 013

Ecotonic® 1000 e Relaxiva® notte: two new references in Difass' portfolio

Products difass en en 014

VIRUSTOP MOUTHWASH

Products difass en en 015

Sollevart®: from today on the market new enhanced formula

Publications difass en en 016

Prother® 5 and diabetic population

Publications difass en en 017

Whey supplementation in malnourished patients with advanced cancer undergoing chemotherapy

Products difass en en 018

The Ministry of Health has ruled on food supplements containing turmeric

Fairs and conventions difass en en 019

Difass participates to the 58° SIN Congress 2019

Publications difass en en 020

Update: Difass obtains also a European patent for a formulation with alpha–lipoic acid

Fairs and conventions difass en en 021

Difass participates to Neurotology Opinions 2019

Publications difass en en 022

Difass obtains an Italian patent on a formulation with alpha–lipoic acid

Fairs and conventions difass en en 023

Difass will partecipate at the 5° AIOG National Congress

Fairs and conventions difass en en 024

Difass partecipate at the 15° edition of Updates in Vestibology – Reggio Emilia

Fairs and conventions difass en en 025

Difass partecipates at the IV Update in Vestibology – Arenzano (GE)

Publications difass en en 026

Difass obtains European patent on usage of antidyslipidaemic compositions on nephritic patients

Fairs and conventions difass en en 027

Difass takes part at the 3° National Congress of the Audiovestibology Cenacle

Products difass en en 028

Levareflux®, Dibuzin®, Sollevart® and Sinustop®: four new references in Difass' portfolio

Products difass en en 029

Soltux® Plus and Soltux® Spray: Soltux® line extension has two new references

Fairs and conventions difass en en 030

Difass takes part at the 10° Clinical Vestibology Course – Pisa

Fairs and conventions difass en en 031

Difass takes part at the 6° Clinical Vestibology Course – Padova

Fairs and conventions difass en en 032

Difass takes part at the 105° SIO Congress

Products difass en en 033

19% Deductibility for food for special medical purposes

Fairs and conventions difass en en 034

Difass takes part at Vertigoforum – Clinical Vestibology Course

Fairs and conventions difass en en 035

Difass takes part at the XXIV Siop National Congress

Fairs and conventions difass en en 036

Difass takes part at CPHI 2017

Fairs and conventions difass en en 037

Difass takes part at the 47° Interregional Congress of the Othorinolaryngology Audiology

Fairs and conventions difass en en 038

Difass takes part at SIFC National Congress

Fairs and conventions difass en en 039

Difass takes part at the 56° Congress of the Roman–Latial Group of Otorhinolaryngology

Products difass en en 040

Difass International and Expharma Limited: license agreement on Repenil®

Products difass en en 041

Diflaselin® Junior e Prother® 5: from 1st September 2017 two new references in Difass' portfolio

Fairs and conventions difass en en 042

Difass takes part in the 5th VIS National Congress

Fairs and conventions difass en en 043

Difass takes part in the National Congress of the Italian Audiovestibology Cenacle

Fairs and conventions difass en en 044

Difass takes part in the 3° SIR National Congress

Fairs and conventions difass en en 045

27–30 settembre Siena, Difass al XXXVI Congresso Nazionale SIAF

Products

The new website for the Prother® family is online at www.prother.it

Products difass en en 046

Vertistop® D e Vertistop® L: two new references in Difass International portfolio

Publications difass en en 047

Difass, a very ancient story: Pianeta Salute writes about the company

Products difass en en 048

Dynafort® Neo, Fortestat® a Kinatrofina® Baby: from 1st Semptember 2016, three new references in

Publications difass en en 049

Difass International obtains Italian patent on usage of antidyslipidaemic compositions

Publications difass en en 050

Difass International obtains patent in China on usage of resveratrol and essential oil of cloves for

Fairs and conventions difass en en 051

25/28 May 2016: Difass at 103rd NATIONAL CONGRESS SIO Italian Society of Otorhinolaryngology

Products difass en en 052

FOLISID C® & FOLISID FORTE®: from May the 1st 2016, two new references in portfolio.

Products difass en en 053

Agenin®3: NEW MONTHLY PACKAGING IN HARD CAPSULE

Products difass en en 054

Betberry80: from the 1st of May 2016, a new evolved formula on the market

Products difass en en 055

SAMBUCI®: from October 1, 2015 the new reference on the market available for physicians

Products difass en en 056

From Diflase® to Diflaselin®: brand name change

Products difass en en 057

MEZINAT EFFE®: the new Difass International formula to alleviate the sleep disorders

Products difass en en 058

January 2015: Vitalbì® Plus the new Difass International. GLUTEN FREE

Products difass en en 059

SOLTUX® the new VS07D®: Extract of Adhatoda vasica s.e. titrated to 0.7% in vasicine and 1.5% in

Products difass en en 060

Diflaselin®: gluten free

Products difass en en 061

September 2014: the catalog is enriched by a new reference Diflase®

Fairs and conventions difass en en 062

6–7 June 2014, Rome, Difass International at The 9th Lipidclub & Therapeutic Apheresis

Fairs and conventions difass en en 063

6–7 June 2014, Rimini, Difass International at Riminiinforma 2° Edition

Publications difass en en 064

Efficacy and Safety of Dif1stat® for the Treatment of Secondary Dyslipidemia in Chronic Kidney

Products difass en en 065

1st December 2013: DIVITAL®, a new Food for Special Medical Purposes

Fairs and conventions difass en en 066

27th–29th November 2013, Rome 27° National Congress SISA

Products difass en en 067

1st October 2013: PUFACOL® a new patented reference on the market

Fairs and conventions difass en en 068

7th–8th June 2013, Rimini, RIMINI IN_FORMA, Medicina Moderna e Integrazione Alimentare

Fairs and conventions difass en en 069

25th –26th May 2013, Rome, III ROMA SONNO National Congress

Fairs and conventions difass en en 070

20th–21st September 2012 III SINUT National Congress

Fairs and conventions difass en en 071

LIPID CLUB, 23rd–24th May 2012, San Gemini

Fairs and conventions difass en en 072

XXI AIUG National Congress, 6th–8th November 2011, Turin

Fairs and conventions difass en en 073

SINUT 25th February 2011